Macitentan NOBEL 10 mg, Filmtabletten - 30 Swissmedic Key 69835001 Registration Holder NOBEL Pharma Schweiz AG Name Macitentan NOBEL 10 mg, Filmtabletten Date of registration 03.12.2025 Introduction of Sequence 03.12.2025 ATC-Classification Macitentan (C02KX04) Revision date WHO WHO-DDD Valid until 02.12.2030 Index Therapeuticus (BSV) Show package size 30 Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Deductible k.A. Feedback FB GTIN 7680698350019 Medication Code Synthetika Pharmacode Disponibility
Composition Filmtablette: macitentanum 10 mg, lactosum monohydricum 39.21 mg, cellulosum microcristallinum, crospovidonum, povidonum K 30, polysorbatum 80, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, glyceroli monocaprylocapras, natrii laurilsulfas corresp. natrium 0.0067 mg, E 171, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose additional_information Macitentanum 10 mg Filmtablette
Inactive agents Dose additional_information Cellulosum Microcristallinum Crospovidonum E 171 color. Glyceroli Monocaprylocapras Lactose Monohydrate 39.21 mg Magnesii Stearas Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Polysorbatum 80 Povidonum K 30 Pro Compresso Obducto Talcum
Source Data was imported : 08.07.2026
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
